Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results
1990; Elsevier BV; Volume: 54; Issue: 6 Linguagem: Inglês
10.1016/s0015-0282(16)53999-5
ISSN1556-5653
AutoresPier Luigi Venturini, V. Fasce, S. Costantini, Paola Anserini, Silvia Cucuccio, Luigi De Cecco,
Tópico(s)Reproductive System and Pregnancy
ResumoThirty-two patients with laparoscopic diagnosis of endometriosis were treated for 6 months with the gonadotropin-releasing hormone agonist goserelin depot. Hormonal and clinical evaluations were conducted during treatment and for a 6-month follow-up period. Serum 17β-estradiol levels were sharply suppressed. Luteinizing hormone was also decreased, whereas follicle-stimulating hormone, after an initial fall, gradually rose to pretreatment levels. Ovarian androgenic production was less inhibited, total testosterone being the only significantly suppressed hormone. There was a marked improvement of signs and symptoms of endometriosis and a 47.3% reduction of laparoscopic score. The results of this study suggest that goserelin depot provides a very good suppression of ovarian estrogen production and is highly effective in decreasing the symptoms of endometriosis with an acceptable compliance by the patient.
Referência(s)